Statins inhibit platelet PAR-1 receptors: The PAR-1 inhibition by statins (PARIS) trial

被引：0
|
作者：
Serebruany, V
Miller, M
Malinin, A
Pokov, A
Lowry, D
Hennekens, C
机构：
[1] Johns Hopkins Univ, HeartDrug Rsch LLC, Towson, MD USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Univ Miami, Sch Med, Miami, FL USA
[4] Midatlan Cardiovasc Associates, Towson, MD USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3113
引用
收藏
页码：U727 / U727
页数：1
相关论文
共 50 条
  • [21] Exquisite Synthesis of a Designed PAR-1 Antagonist
    Miao, Hua-Ming
    Zhao, Gui-Long
    Zhang, Lin-Shan
    Shao, Hua
    Wang, Jian-Wu
    HELVETICA CHIMICA ACTA, 2011, 94 (11) : 1981 - 1993
  • [22] PAR-1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact
    Judge, M. H.
    Jennings, L.
    Moliterno, D.
    Hord, E.
    Ecob, R.
    Tricoci, P.
    Smyth, S.
    Rorick, T.
    Kotha, J.
    Storey, R. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 444 - 444
  • [23] Discovery of an orally available PAR-1 antagonist
    Lee, S.
    Park, C-M
    Song, J-W
    Lim, D-C
    Cho, W-Y
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 555 - 555
  • [24] PAR-1 antagonists: current state of evidence
    Saurav Chatterjee
    Abhishek Sharma
    Debabrata Mukherjee
    Journal of Thrombosis and Thrombolysis, 2013, 35 : 1 - 9
  • [25] Low concentrations of dabigatran prevent thrombin-mediated platelet aggregation and partially inhibit PAR-1 and PAR-4 activation
    Ofosu, F.
    Song, Y.
    Bhakta, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 533 - 533
  • [26] Cell polarity and microtubules: The PAR-1 connection?
    Benton, R
    Shulman, JM
    St Johnston, D
    DEVELOPMENTAL BIOLOGY, 2000, 222 (01) : 281 - 281
  • [27] Stimulation of PAR-1 or PAR-4 promotes a similar pattern of platelet-mediated angiogenesis
    Etulain, J.
    Mena, A.
    Negrotto, S.
    Schattner, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 270 - 270
  • [28] Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin
    Boncler, MA
    Koziolkiewicz, M
    Watala, C
    THROMBOSIS RESEARCH, 2001, 104 (03) : 215 - 222
  • [29] PAR-1 and PAR-2 receptor mediated actions in the human intestine
    Mueller, K.
    Michel, K.
    Krueger, D.
    Demir, I. E.
    Ceyhan, G. O.
    Zeller, F.
    Kreis, M. E.
    Schemann, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 16 - 16
  • [30] Discovery and development of the selective PAR-1 antagonist Atopaxar
    Kawahara, Tetsuya
    Kawaguchi, Shinki
    Kogushi, Motoji
    Kotake, Makoto
    Matsuoka, Toshiyuki
    Matsuura, Fumiyoshi
    Musha, Takashi
    Sato, Nobuaki
    Suzuki, Syuichi
    Takada, Masahiro
    Terauchi, Taro
    Clark, Richard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345